Praxis Precision Medicines: Tim Kelly

Tim Kelly has become CFO of Praxis Precision Medicines, a biopharmaceutical company translating genetic results into treatments for central nervous system disorders. He joins the Cambridge, Massachusetts-based firm from Foundation Medicine, a subsidiary of Roche, where he was CFO and head of corporate management. Prior to that, he held various roles at Roche, most recently finance and corporate services director at Roche Pharma in the UK. Kelly holds a BA in economics from the College of William and Mary and an MBA from Columbia Business School.